Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 7/14/14 → 7/13/17 |
Funding
- PRA Health Sciences (Prot # GS-US-342-1137 // Prot # GS-US-342-1137)
- Gilead Sciences, Inc (Prot # GS-US-342-1137 // Prot # GS-US-342-1137)
Prot # GS-US-342-1137: A Phase 3, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/GS-5816 Fixed-Dose Combination in Subjects with Chronic HCV Infection and Child-Pugh Class B Cirrhosis
- Flamm, Steven L (PD/PI)
Project: Research project